Propranolol in Adult Patients: Dosing, Contraindications, and Monitoring
Contraindications
Propranolol is absolutely contraindicated in cardiogenic shock, sinus bradycardia and greater than first-degree heart block, bronchial asthma, and known hypersensitivity to propranolol. 1
Additional critical contraindications and precautions include:
- Decompensated heart failure with evidence of rales, S3 gallop, or high risk for shock 2
- Severe reactive airway disease or chronic obstructive pulmonary disease 3, 4
- Second- or third-degree heart block (in absence of pacemaker) 5
- Symptomatic bradycardia (heart rate <50 beats per minute) 2
- Hypotension (systolic blood pressure <90 mm Hg) 2
- Low-output states with oliguria or sinus tachycardia reflecting low stroke volume 2
Starting Dose
For Hypertension
The usual initial dose is 80 mg once daily of extended-release propranolol, whether used alone or added to a diuretic. 1 For immediate-release formulations in acute settings, start with 0.15 mg/kg IV 6 or 2.5-5 mg IV bolus over 2 minutes, up to 3 doses for acute rate control 6. For oral immediate-release therapy, begin with 30-60 mg daily in divided doses 5.
For Angina Pectoris
Start with 80 mg extended-release once daily, with gradual increases at 3-7 day intervals 1.
For Supraventricular Tachycardia
Intravenous propranolol 0.5-1 mg over 1 minute, repeated up to a total dose of 0.1 mg/kg if required 7. For chronic oral therapy, 30-60 mg daily in divided or single dose with long-acting formulations 5.
Special Populations
In patients with mild wheezing or chronic obstructive pulmonary disease concerns, use a reduced dose of a short-acting cardioselective agent (e.g., 12.5 mg metoprolol orally) rather than complete avoidance 2.
Titration Schedule
Hypertension
Increase dosage to 120 mg once daily or higher until adequate blood pressure control is achieved, with the usual maintenance dose being 120-160 mg once daily 1. The time needed for full hypertensive response ranges from a few days to several weeks 1.
Angina Pectoris
Gradually increase at 3-7 day intervals until optimal response is obtained, with the average optimal dosage being 160 mg once daily 1.
Acute Myocardial Infarction/Unstable Angina
For IV metoprolol (as reference for beta-blocker titration): 5 mg increments by slow IV administration over 1-2 minutes, repeated every 5 minutes for a total initial dose of 15 mg 2. In patients who tolerate the full IV dose, oral therapy can be initiated 15 minutes after the last IV dose at 25-50 mg every 6 hours for 48 hours, then maintenance dose up to 100 mg twice daily 2.
Heart Failure
For beta-blockers in heart failure, start with very low doses and double every 1-2 weeks if the preceding dose was well tolerated 8. Most patients can be managed as outpatients with this titration approach 8.
Target Daily Dose
Hypertension
The usual maintenance dosage is 120-160 mg once daily, though some patients may require up to 640 mg 1.
Angina Pectoris
The average optimal dosage is 160 mg once daily, with the value and safety of dosages exceeding 320 mg per day not established 1.
Migraine Prophylaxis
The usual effective dose range is 160-240 mg once daily 1. If satisfactory response is not obtained within 4-6 weeks after reaching maximal dose, therapy should be discontinued 1.
Hypertrophic Subaortic Stenosis
The usual dosage is 80-160 mg once daily 1.
Monitoring Recommendations
During Initiation and Titration
Monitor heart rate, blood pressure, and continuous ECG during IV beta-blocker therapy, with frequent checks and auscultation for rales and bronchospasm 2.
Target resting heart rate is 50-60 beats per minute unless a limiting side effect is reached 2.
Ongoing Monitoring
- Monitor for evidence of heart failure symptoms, fluid retention, hypotension, and symptomatic bradycardia 8
- Adequacy of heart rate control should be assessed during physical activity as well as at rest 6
- In acute settings with IV propranolol, observations should occur 30 minutes apart for a total observation period of 2-4 hours 9
Management of Adverse Effects During Titration
If worsening heart failure symptoms occur, first increase the dose of diuretics or ACE-inhibitor; temporarily reduce the dose of beta-blocker if necessary 8.
If hypotension develops, first reduce the dose of vasodilators; reduce the dose of beta-blocker if necessary 8.
For bradycardia, reduce or discontinue drugs that may lower heart rate; reduce dose of beta-blocker if necessary, but discontinue only if clearly necessary 8.
Always consider reintroduction and/or uptitration of the beta-blocker when the patient becomes stable 8.
Critical Safety Considerations
In adult burn patients, propranolol doses averaging 0.61 mg/kg/day resulted in frequent episodes of hypotension (72% of patients) or bradycardia (15%), with 32% having at least one dose held for hypotension 10. This suggests adults do not tolerate the higher doses reported in pediatric populations and require more conservative dosing 10.
Propranolol should not be discontinued abruptly; if treatment is to be stopped, reduce dosage gradually over a period of a few weeks 1.